Facet Life Sciences is a regulatory affairs and product development strategy partner for emerging biotech and science companies. They guide clients through FDA pathways for drug, biologic, and medical device development.
Facet Life Sciences specializes in guiding small life science companies through the complex journey of drug, biologic, and medical device development. They offer tailored solutions for every stage, from initial concept through commercialization, focusing on nimble, entrepreneurial approaches to navigate FDA's regulatory pathways with precision and expertise. Their services include acting as a US Agent, providing regulatory strategy and development guidance, gap analysis, medical writing for submission documents, meeting facilitation with the FDA, and regulatory submission leadership. Facet fosters collaborative relationships with the FDA (CDER, CBER, and CDRH) on behalf of their clients to progress products through development and secure market acceptance. With a team bringing decades of experience in product development, nonclinical, clinical, CMC, regulatory affairs, and commercial launch, Facet helps create and execute effective development plans and launch strategies. They are committed to aggressive, scientifically sound progress, aligning strategies with client resources and business objectives to translate science into product value and answers for investors or partners.
About
**Who they are** Facet Life Sciences is a regulatory affairs and product development strategy partner for emerging biotech and science companies. They guide clients through FDA pathways for drug, biologic, and medical device development.
**Expertise & scope** * Regulatory affairs and product development strategy * Guidance through FDA pathways for drug, biologic, and medical device development * US Agent services, communicating directly with the US FDA on behalf of sponsors * Support for companies without a US presence requiring a US Agent to bring investigational or marketed products into the US * Assistance for companies with a US presence seeking contract US agent support when in-house expertise or resources are limited * Fostering collaborative relationships with FDA (CDER, CBER, and CDRH) * Facilitating communication with FDA via secure email, phone, and fax to obtain regulatory answers and address FDA inquiries * Preparation and conduct of successful meetings with the FDA
**Reputation / proof points** * Headquartered in the Midwest
Additional information
Facet Life Sciences acts as a US Agent, serving as the direct communication channel with the US FDA for sponsors. This role is crucial for companies lacking a US presence to introduce investigational or marketed products into the United States. For established US entities, engaging a contract US agent is beneficial when internal regulatory expertise or resources are constrained. The agency emphasizes building dynamic relationships with the FDA, including CDER, CBER, and CDRH, to advance product development. They leverage secure communication methods to expedite responses to regulatory questions and assist clients in preparing for and conducting meetings with the FDA.
Key Highlights
Facet Life Sciences provides US Agent services, communicating directly with the US FDA on behalf of sponsors.
Source
“As a US Agent, we communicate directly with the US FDA on behalf of a sponsor.”
They guide clients through FDA pathways for drug, biologic, and medical device development.
Source
“They guide clients through FDA pathways for drug, biologic, and medical device development.”
The company fosters collaborative relationships with FDA entities including CDER, CBER, and CDRH.
Source
“We foster collaborative, dynamic relationships with FDA (CDER, CBER, and CDRH) on your behalf to progress your product(s) through development.”
Certifications & Trust Signals
Facet Life Sciences is headquartered in the Midwest.
Source
“headquartered in the Midwest”
Buyer Snapshot
Best for
Emerging biotech and science companies
Companies needing FDA regulatory guidance
Companies requiring a US Agent for market entry
How engagement typically works
Direct communication with FDA on behalf of sponsor
Collaborative relationship building with FDA
Facilitating FDA meetings
Typical deliverables
FDA pathway guidance
US Agent representation
Regulatory question resolution
Meeting preparation and support
Good to know
Best when seeking expert guidance for navigating FDA regulatory processes for drugs, biologics, or medical devices.